R&D Partner Content 2nd Innovation in Obesity Therapeutics Summit Hear from the titans of the pharmaceutical industry, including Novo Nordisk, Eli Lilly, and Boehringer Ingelheim, as well as innovative biotechs
Partner Content Partner Content Maximising the Therapeutic Potential of Complement Mediation... Capturing the Industry’s Most Exciting Developments in Complement-Based Therapeutics
R&D Partner Content The 18th PFS & Injectable Drug Devices Europe Conference Kickstart 2026 in London to explore advances in drug delivery with the experts.
R&D Partner Content The Antifibrotic Drug Development Summit returns this Novemb... Harness cross-fibrotic insights and make new connections this November in Boston
Partner Content Partner Content 7th Cell Therapy Analytical Development Summit Join us in fast-tracking the next era of safe, potent, and robust cell therapies to market!
Partner Content Partner Content 7th TIL Therapies Summit Driving the Next Generation of TIL Therapies for Solid Tumors
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.